155 related articles for article (PubMed ID: 36403480)
1. Sirtuin 1 aggravates hypertrophic heart failure caused by pressure overload via shifting energy metabolism.
Van Le TN; Zoungrana LI; Wang H; Fatmi MK; Ren D; Krause-Hauch M; Li J
Biochem Biophys Res Commun; 2022 Dec; 637():170-180. PubMed ID: 36403480
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.
Wang L; Quan N; Sun W; Chen X; Cates C; Rousselle T; Zhou X; Zhao X; Li J
Cardiovasc Res; 2018 May; 114(6):805-821. PubMed ID: 29409011
[TBL] [Abstract][Full Text] [Related]
3. α-Ketoglutarate improves cardiac insufficiency through NAD
Yu H; Gan D; Luo Z; Yang Q; An D; Zhang H; Hu Y; Ma Z; Zeng Q; Xu D; Ren H
Mol Med; 2024 Jan; 30(1):15. PubMed ID: 38254035
[TBL] [Abstract][Full Text] [Related]
4. Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress.
Kumar A; Supowit S; Potts JD; DiPette DJ
Physiol Rep; 2019 Nov; 7(21):e14269. PubMed ID: 31724338
[TBL] [Abstract][Full Text] [Related]
5. Inducible Cardiac-Specific Deletion of Sirt1 in Male Mice Reveals Progressive Cardiac Dysfunction and Sensitization of the Heart to Pressure Overload.
Sanz MN; Grimbert L; Moulin M; Gressette M; Rucker-Martin C; Lemaire C; Mericskay M; Veksler V; Ventura-Clapier R; Garnier A; Piquereau J
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658614
[TBL] [Abstract][Full Text] [Related]
6. DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism.
Furukawa N; Koitabashi N; Matsui H; Sunaga H; Umbarawan Y; Syamsunarno MRAA; Yamaguchi A; Obokata M; Hanaoka H; Yokoyama T; Kurabayashi M
Heart Vessels; 2021 Jan; 36(1):136-146. PubMed ID: 33073318
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
Bugyei-Twum A; Ford C; Civitarese R; Seegobin J; Advani SL; Desjardins JF; Kabir G; Zhang Y; Mitchell M; Switzer J; Thai K; Shen V; Abadeh A; Singh KK; Billia F; Advani A; Gilbert RE; Connelly KA
Cardiovasc Res; 2018 Oct; 114(12):1629-1641. PubMed ID: 29800064
[TBL] [Abstract][Full Text] [Related]
9. Taurine protects against cardiac dysfunction induced by pressure overload through SIRT1-p53 activation.
Liu J; Ai Y; Niu X; Shang F; Li Z; Liu H; Li W; Ma W; Chen R; Wei T; Li X; Li X
Chem Biol Interact; 2020 Feb; 317():108972. PubMed ID: 32017914
[TBL] [Abstract][Full Text] [Related]
10. Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice.
Tan WS; Mullins TP; Flint M; Walton SL; Bielefeldt-Ohmann H; Carter DA; Gandhi MR; McDonald HR; Li J; Moritz KM; Reichelt ME; Gallo LA
Am J Physiol Regul Integr Comp Physiol; 2018 Jun; 314(6):R858-R869. PubMed ID: 29443547
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion.
Han Y; Sun W; Ren D; Zhang J; He Z; Fedorova J; Sun X; Han F; Li J
Redox Biol; 2020 Jul; 34():101538. PubMed ID: 32325423
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na
Nie J; Duan Q; He M; Li X; Wang B; Zhou C; Wu L; Wen Z; Chen C; Wang DW; Alsina KM; Wehrens XHT; Wang DW; Ni L
J Cell Physiol; 2019 Jul; 234(7):11587-11601. PubMed ID: 30488495
[TBL] [Abstract][Full Text] [Related]
14. Multimodality Imaging of Inflammation and Ventricular Remodeling in Pressure-Overload Heart Failure.
Glasenapp A; Derlin K; Wang Y; Bankstahl M; Meier M; Wollert KC; Bengel FM; Thackeray JT
J Nucl Med; 2020 Apr; 61(4):590-596. PubMed ID: 31653713
[TBL] [Abstract][Full Text] [Related]
15. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure.
Hu D; Cui YX; Wu MY; Li L; Su LN; Lian Z; Chen H
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1525-H1537. PubMed ID: 32383996
[TBL] [Abstract][Full Text] [Related]
17. Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure.
Muthuramu I; Mishra M; De Geest B
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884897
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
[TBL] [Abstract][Full Text] [Related]
19. Genetically induced moderate inhibition of 20S proteasomes in cardiomyocytes facilitates heart failure in mice during systolic overload.
Ranek MJ; Zheng H; Huang W; Kumarapeli AR; Li J; Liu J; Wang X
J Mol Cell Cardiol; 2015 Aug; 85():273-81. PubMed ID: 26116868
[TBL] [Abstract][Full Text] [Related]
20. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
